| 1 |
35419185 | The Effects of Febuxostat on Urine NGAL and Urine KIM-1 in Patients with Hyperuricemia. | 2022 |
2 |
| 2 |
35635326 | Mechanisms of action of the SGLT2 inhibitor canagliflozin on tubular inflammation and damage: a post-hoc mediation analysis of the CANVAS trial. | 2022 May 30 |
1 |
| 3 |
33140691 | Biomarkers as predictors of renal damage in neonates undergoing cardiac surgery. | 2021 Nov |
1 |
| 4 |
33272156 | The Pattern of Cyclosporine Nephrotoxicity and Urinary Kidney Injury Molecule 1 in Allogenic Hematopoietic Stem Cell Transplant Patients. | 2021 Jun |
1 |
| 5 |
33771116 | Effect of 0.9% NaCl compared to plasma-lyte on biomarkers of kidney injury, sodium excretion and tubular transport proteins in patients undergoing primary uncemented hip replacement - a randomized trial. | 2021 Mar 26 |
1 |
| 6 |
34355651 | Diagnostic performance of kidney injury molecule-1 for detection of abnormal urinary albumin-to-creatinine ratio in type 2 diabetes mellitus. | 2021 Nov 2 |
1 |
| 7 |
34729216 | Human kidney injury molecule-1 as a urine biomarker differentiating urothelial and renal cell carcinoma. | 2021 |
2 |
| 8 |
31483944 | Circulating kidney injury molecule-1 as a biomarker of renal parameters in diabetic kidney disease. | 2020 Mar |
1 |
| 9 |
32487784 | Kidney injury molecule-1: A potential marker of renal recovery after laparoscopic sleeve gastrectomy. | 2020 Jun 30 |
1 |
| 10 |
32541154 | KIM-1 and Kidney Disease Progression in Autosomal Dominant Polycystic Kidney Disease: HALT-PKD Results. | 2020 |
1 |
| 11 |
32841436 | N-acetyl-b-D-glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality. | 2020 Dec |
1 |
| 12 |
30989103 | Baseline urinary KIM-1 concentration in detecting acute kidney injury should be interpreted with patient pre-existing nephropathy. | 2019 May |
2 |
| 13 |
31372130 | Evaluation of kidney injury molecule-1 as a disease progression biomarker in diabetic nephropathy. | 2019 Jul-Aug |
2 |
| 14 |
31538126 | The role of kidney injury molecule-1 in predicting cardiorenal syndrome type 1 after diuretic treatment. | 2019 |
1 |
| 15 |
31646460 | Kidney injury molecule-1, a sensitive and specific marker for identifying acute proximal tubular injury, can be used to predict renal functional recovery in native renal biopsies. | 2019 Dec |
1 |
| 16 |
30110569 | Kidney injury molecule-1 identifies antemortem injury in postmortem adult and fetal kidney. | 2018 Dec 1 |
1 |
| 17 |
30180818 | Urinary biomarkers for early detection of platinum based drugs induced nephrotoxicity. | 2018 Sep 4 |
1 |
| 18 |
27852120 | KIM-1 Is a Potential Urinary Biomarker of Obstruction: Results from a Prospective Cohort Study. | 2017 Feb |
2 |
| 19 |
28103129 | The role of urinary KIM-1, NGAL, CA19-9 and β2-microglobulin in the assessment of ureteropelvic junction obstruction in adults. | 2017 Nov |
1 |
| 20 |
28103909 | Potential diagnostic biomarkers for chronic kidney disease of unknown etiology (CKDu) in Sri Lanka: a pilot study. | 2017 Jan 19 |
1 |
| 21 |
28584738 | Performance Characteristics of Kidney Injury Molecule-1 In Relation to Creatinine, Urea, and Microalbuminuria in the Diagnosis of Kidney Disease. | 2017 Apr-Jun |
3 |
| 22 |
28596840 | Novel SGLT2 inhibitor: first-in-man studies of antisense compound is associated with unexpected renal effects. | 2017 Feb |
1 |
| 23 |
28884615 | Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease. | 2017 Nov |
1 |
| 24 |
28979926 | A Comparative Study of the Predictive Values of Urinary Acute Kidney Injury Markers Angiogenin and Kidney Injury Molecule 1 for the Outcomes of Kidney Allografts. | 2017 Sep |
1 |
| 25 |
31966633 | Increased expression of kidney injury molecule-1 and matrix metalloproteinase-3 in severe Plasmodium falciparum malaria with acute kidney injury. | 2017 |
2 |
| 26 |
25923545 | Urinary kidney injury molecule-1 levels as a marker of early kidney injury in hypertensive patients. | 2016 Oct |
1 |
| 27 |
26511274 | Plasma kidney injury molecule-1 in heart failure: renal mechanisms and clinical outcome. | 2016 Jun |
2 |
| 28 |
26538632 | Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model. | 2016 Jul |
1 |
| 29 |
26751954 | Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography. | 2016 |
1 |
| 30 |
26795762 | Urinary kidney injury molecule-1 levels in renal stone patients. | 2016 Sep |
3 |
| 31 |
27132791 | Kidney Injury Molecule Levels in Type 2 Diabetes Mellitus. | 2016 Nov |
2 |
| 32 |
27270293 | Relationship of proximal tubular injury to chronic kidney disease as assessed by urinary kidney injury molecule-1 in five cohort studies. | 2016 Sep |
2 |
| 33 |
27296256 | [Acute kidney injury and tubular biomarkers after hematopoietic stem cell transplantation]. | 2016 |
1 |
| 34 |
27321055 | Associations between urinary kidney injury biomarkers and cardiovascular mortality risk in elderly men with diabetes. | 2016 Aug |
3 |
| 35 |
27605629 | Renal Effects of Antisense-Mediated Inhibition of SGLT2. | 2016 Nov |
1 |
| 36 |
27642395 | Kidney injury molecule-1 and microalbuminuria levels in Zambian population: biomarkers of kidney injury. | 2016 |
1 |
| 37 |
27858892 | Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B. | 2016 Nov |
1 |
| 38 |
27966578 | Urinary KIM-1: a novel biomarker for evaluation of occupational exposure to lead. | 2016 Dec 14 |
1 |
| 39 |
25316431 | Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus. | 2015 Jan |
1 |
| 40 |
25784666 | Kidney injury molecule-1 and the loss of kidney function in diabetic nephropathy: a likely causal link in patients with type 1 diabetes. | 2015 Jun |
1 |
| 41 |
26248472 | Urinary KIM-1 in children undergoing nephrotoxic antineoplastic treatment: a prospective cohort study. | 2015 Dec |
1 |
| 42 |
26350438 | Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study. | 2015 Nov 6 |
1 |
| 43 |
26407820 | Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. | 2015 Nov |
1 |
| 44 |
24598218 | Estimation of kidney injury molecule-1 (Kim-1) in patients with lupus nephritis. | 2014 Jul |
1 |
| 45 |
24656453 | Urinary kidney injury molecule 1 (KIM-1) and interleukin 18 (IL-18) as risk markers for heart failure in older adults: the Health, Aging, and Body Composition (Health ABC) Study. | 2014 Jul |
1 |
| 46 |
24904085 | Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. | 2014 Oct |
1 |
| 47 |
24923577 | Urinary kidney injury molecule-1 and the risk of cardiovascular mortality in elderly men. | 2014 Aug 7 |
1 |
| 48 |
23200959 | Is urinary kidney injury molecule-1 a noninvasive marker for renal scarring in children with vesicoureteral reflux? | 2013 Jan |
1 |
| 49 |
23220287 | Urinary kidney injury molecule 1 and incidence of heart failure in elderly men. | 2013 Apr |
1 |
| 50 |
23837450 | Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy. | 2013 Jul 9 |
1 |